NCT03856216 2025-10-16Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell TransplantationM.D. Anderson Cancer CenterPhase 2 Terminated15 enrolled
NCT03103971 2024-04-10huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaFred Hutchinson Cancer CenterPhase 1 Terminated55 enrolled
NCT01434472 2021-07-20High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell LymphomaFred Hutchinson Cancer CenterPhase 2 Terminated20 enrolled 15 charts
NCT03579888 2021-06-02CD19-Specific T Cells Post AlloSCTM.D. Anderson Cancer CenterPhase 1 Terminated4 enrolled
NCT02145039 2019-12-26Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic DiseasesMasonic Cancer Center, University of MinnesotaPhase NA Terminated2 enrolled 11 charts